All stock lists
Kraft Heinz (New York Stock Exchange:KHC)
US · Delayed Price · Currency is USD
Also listed: KHNZ.DE, KHC.SWConsumer Defensive · Packaged Foods
$25.11+$0.63 (+2.57%)
Market cap
$29.7B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 6, 2015
Website
Insider Score
––Not scored
KHC Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From KHC’s reported statements · Q3 2026 (trailing 12 months)
Profitability3 / 20
Loses money on what it sells.
- Revenue
- $24.78B
- Net income
- -$3.47B
- Net margin
- -14.0%
Leverage15 / 20
Little or no net debt.
- Total debt
- $18.00B
- Cash
- $1.89B
- Debt / equity
- 0.50
Liquidity7 / 20
Covers near-term obligations, without much room.
- Current assets
- $8.66B
- Current liabilities
- $8.49B
- Current ratio
- 1.02
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $4.34B
- Free cash flow
- $3.53B
- FCF margin
- 14.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 1186.0M
- Share growth (1y)
- 0.2%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
KHC Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 26, 2026 | Jun 27, 2026 | Mar 28, 2026 | Dec 27, 2025 | Sep 27, 2025 | Jun 28, 2025 |
| Revenue | $6.12 B | $6.26 B | $6.05 B | $6.35 B | $6.24 B | $6.35 B |
| Revenue Growth (YoY) | -1.96 % | -1.42 % | 0.80 % | -3.38 % | -2.29 % | -1.91 % |
| Cost of Revenue | $4.13 B | $4.23 B | $3.83 B | $4.28 B | $4.25 B | $4.17 B |
| Gross Profit | $1.99 B | $2.03 B | $2.22 B | $2.07 B | $1.99 B | $2.18 B |
| SG&A Expense | $1.04 B | $1.11 B | $1.06 B | $983.00 M | $930.00 M | $891.00 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $1.11 B | $8.46 B | $1.07 B | $988.00 M | $965.00 M | $10.16 B |
| Operating Income | $875.00 M | -$6.43 B | $1.15 B | $1.08 B | $1.02 B | -$7.97 B |
| Pretax Income | $704.00 M | -$6.38 B | $1.01 B | $897.00 M | $807.00 M | -$8.17 B |
| Tax Provision | $168.00 M | -$916.00 M | $211.00 M | $249.00 M | $194.00 M | -$344.00 M |
| Net Income | $544.00 M | -$5.46 B | $798.00 M | $651.00 M | $615.00 M | -$7.82 B |
| EPS (Basic) | $0.46 | -$4.60 | $0.67 | $0.55 | $0.52 | -$6.60 |
| EPS (Diluted) | $0.46 | -$4.60 | $0.67 | $0.55 | $0.52 | -$6.60 |
| Shares Outstanding | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 1.18 B | 1.19 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.